The FDA has approved finerenone (Kerendia, Bayer) for the treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes.
Megan M. Pantos, PharmD
Advertisement
Articles by Megan M. Pantos, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
3
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
4
